Evoke plc (LON:EVOK – Get Free Report)’s share price was down 10% during trading on Thursday . The company traded as low as GBX 50.20 ($0.65) and last traded at GBX 51.73 ($0.67). Approximately 65,066,164 shares traded hands during trading, an increase of 1,994% from the average daily volume of 3,107,171 shares. The stock had previously closed at GBX 57.45 ($0.74).
Wall Street Analyst Weigh In
Several brokerages recently weighed in on EVOK. Jefferies Financial Group reaffirmed a “buy” rating and issued a GBX 140 ($1.81) target price on shares of Evoke in a report on Monday, December 16th. Berenberg Bank reduced their price objective on shares of Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a “buy” rating on the stock in a report on Wednesday, December 4th.
Read Our Latest Stock Report on Evoke
Evoke Trading Down 1.1 %
Evoke (LON:EVOK – Get Free Report) last issued its earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) earnings per share for the quarter. Evoke had a negative return on equity of 517.98% and a negative net margin of 8.50%. As a group, equities research analysts predict that Evoke plc will post 12.7648305 EPS for the current year.
Insider Transactions at Evoke
In related news, insider Andrea Gisle Joosen purchased 14,572 shares of the business’s stock in a transaction that occurred on Tuesday, January 28th. The shares were purchased at an average cost of GBX 70 ($0.91) per share, for a total transaction of £10,200.40 ($13,202.69). Insiders own 27.00% of the company’s stock.
Evoke Company Profile
Recommended Stories
- Five stocks we like better than Evoke
- How to Use the MarketBeat Stock Screener
- MarketBeat Week in Review – 03/24 – 03/28
- Why is the Ex-Dividend Date Significant to Investors?
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.